TRDA vs XLI
Entrada Therapeutics Inc (TRDA) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
XLI (XLI) common stock.
Latest reported TRDA revenue for 2026-06-30 was $1.8M. Net income was -$82.5M. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
XLI does not have a complete income-statement cache yet.
TRDA currently screens at market cap $274.4M and trailing P/E 12.5. XLI currently screens at market cap $0.
Not investment advice. Open the TRDA and XLI stock pages for the full models.
Not investment advice.